datetime,headline,summary,related,lang,source
2020-11-02 16:58:45-05:00,Intrepid Announces Third Quarter 2020 Results,"DENVER, CO, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Intrepid Potash, Inc. (Intrepid) (NYSE:IPI) today reported its results for the third quarter of 2020. Key…",IPI,en,GlobeNewswire
2020-10-26 15:10:00-05:00,Intrepid Announces Date for Third Quarter 2020 Earnings Release,"DENVER, CO, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Intrepid Potash Inc. (NYSE: IPI) plans to release its third quarter 2020 financial results on Monday,…",IPI,en,GlobeNewswire
2020-10-20 03:53:46-05:00,"Intrepid Potash, Inc. (NYSE:IPI) Sees Large Growth in Short Interest","Intrepid Potash, Inc. (NYSE:IPI) saw a significant growth in short interest in September. As of September 30th, there was short interest totalling 264,400 shares, a growth of 25.2% from the September 15th total of 211,200 shares. Based on an average daily trading volume, of 128,900 shares, the short-interest ratio is currently 2.1 days. Currently, 2.8% […]",IPI,en,Stock Observer
2020-08-20 15:47:24-05:00,Intrepid Potash - Rising From The Dead (NYSE:IPI),"Potash segment can benefit from a more tightening market. Trio segment, which is 30% of Intrepid, offers the advantage of stable prices.",IPI,en,Seeking Alpha
2020-04-28 08:03:00-05:00,"Intrepid Potash's Shares March Higher, Can It Continue?","As of late, it has definitely been a great time to be an investor in Intrepid Potash.",IPI,en,Zacks Investment Research
2020-04-15 10:50:11-05:00,Are Investors Undervaluing Intrepid Potash (IPI) Right Now?,"Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",IPI,en,Zacks Investment Research
2019-11-08 08:08:37-05:00,"Intrepid Potash: My Top 5 Pick, My Colossal Failure","Sold Intrepid Potash, My Top 5 Pick Wednesday. The guide posts that kept changing. What did I actually learn?",IPI,en,Seeking Alpha
2019-11-06 14:04:31-05:00,"Intrepid Potash, Inc. (IPI): Are Hedge Funds Right About This Stock?","World-class money managers like Ken Griffin and Barry Rosenstein only invest their wealthy clients' money after undertaking a rigorous examination of any potential stock. They are particularly successful in this regard when it comes to small-cap stocks, which their peerless research gives them a",IPI,en,Yahoo Finance
2019-10-21 09:49:24-05:00,"One Thing To Remember About The Intrepid Potash, Inc. (NYSE:IPI) Share Price","If you own shares in Intrepid Potash, Inc. (NYSE:IPI) then it's worth thinking about how it contributes to the…",IPI,en,ACI Information Group
2019-09-30 08:57:14-05:00,"Intrepid Potash, Inc. (NYSE:IPI) Might Not Be A Great Investment","Today we'll evaluate Intrepid Potash, Inc. (NYSE:IPI) to determine whether it could have potential as an investment…",IPI,en,Yahoo Finance
2019-09-09 09:13:36-05:00,"Can Intrepid Potash, Inc. (NYSE:IPI) Improve Its Returns?","One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will…",IPI,en,Yahoo Finance
2019-08-22 08:10:11-05:00,Is Intrepid Potash (IPI) Stock Undervalued Right Now?,"Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",IPI,en,Zacks Investment Research
2019-05-08 08:25:03-05:00,Intrepid Potash (IPI) Q1 2019 Earnings Call Transcript -- The Motley Fool,"IPI earnings call for the period ending March 31, 2019.",IPI,en,The Motley Fool
2019-05-07 14:48:10-05:00,Intrepid Potash's (IPI) CEO Bob Jornayvaz on Q1 2019 Results - Earnings Call Transcript,No summary available.,IPI,en,Seeking Alpha
2019-05-07 06:05:12-05:00,"Intrepid Potash beats by $0.01, beats on revenue",No summary available.,IPI,en,Seeking Alpha
2019-05-02 15:32:01-05:00,Intrepid Completes Purchase of Dinwiddie Jal Ranch,"Intrepid Potash, Inc. (IPI) (""Intrepid"") today announced it completed its acquisition of the Dinwiddie Jal Ranch and related water rights (collectively, the ""Dinwiddie Assets"") from the Dinwiddie Cattle Company, LLC. ""The acquisition of the Dinwiddie Assets in the Northern Delaware",IPI,en,Yahoo Finance
2019-04-23 08:30:00-05:00,"Innovation Pharmaceuticals - ""JAMA"" Article Reinforces Need for Novel Oral Mucositis Treatments in Supportive Cancer Care; Company progresses through first stage of review by European Medicines Agency (EMA) regarding Scientific Advice for planned Phase 3 Program","BEVERLY, Mass., April 23, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB: IPIX ) (""the Company""), a clinical stage pharmaceutical company, is pleased to inform shareholders of a recent publication in the Journal of the American Medical Association (JAMA) , a leading independent, international journal for medical professionals, detailing data from a clinical study 1 on the effect of doxepin mouthwash or diphenhydramine-lidocaine-antacid mouthwash vs placebo on radiotherapy-related oral mucositis pain. A corresponding editorial 2 , titled, ""The Search for an Effective Therapy and Pain Relief for Oral Mucositis,"" accompanied the article. Both the published JAMA article and editorial are highly relevant for development of Brilacidin oral rinse under a U.S. Food and Drug Administration (FDA) Fast Track designation as a new drug candidate to decrease the incidence of severe Oral Mucositis (OM) in Head and Neck Cancer (HNC) patients receiving chemoradiation. The clinical study recruited 275 patients randomized 1:1:1 to receive: doxepin; diphenhydramine-lidocaine-antacid; or placebo mouthwash.",IPI,en,Benzinga
2019-03-15 07:00:00-05:00,Innovation Pharmaceuticals Requesting European Medicines Agency (EMA) Input for International Phase 3 Brilacidin Oral Mucositis Program,"BEVERLY, Mass., March 15, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals, (OTCQB: IPIX ) (""the Company""), a clinical stage biopharmaceutical company, is pleased to inform shareholders that necessary documentation has been completed for the European Medicines Agency (EMA) March 15, 2019 submission cycle requesting Scientific Advice to advance Brilacidin oral rinse in a Phase 3 program for the prevention of severe Oral Mucositis (OM) in Head and Neck Cancer (HNC) patients receiving chemoradiation. The documentation is being submitted to the EMA through IPIX Pharma, Ltd., the Innovation Pharmaceuticals Irish subsidiary. As is customary, the Company is seeking Phase 3 scientific guidance from the EMA regarding the Brilacidin OM program. In December, Innovation Pharmaceuticals completed an End-of-Phase 2 Meeting with the U.S. Food and Drug Administration (FDA), during which an acceptable Phase 3 development pathway was agreed upon to advance Brilacidin. For the Phase 3 program, the Company anticipates international clinical trial enrollment, with participating sites located in the U.S. and in Europe.",IPI,en,Benzinga
2019-03-14 08:46:10-05:00,Intrepid Potash: Legacy Business Back To Growth And Water Sales Is Here To Stay,No summary available.,IPI,en,Seeking Alpha
2019-03-12 12:01:04-05:00,"Intrepid Potash, Inc. (IPI) CEO Robert Jornayvaz on Q4 2018 Results - Earnings Call Transcript",No summary available.,IPI,en,Seeking Alpha
2019-03-12 09:05:19-05:00,Intrepid Potash rises ~6% post Q4 earnings beat,No summary available.,IPI,en,Seeking Alpha
2019-03-12 06:05:03-05:00,"Intrepid Potash beats by $0.02, beats on revenue",No summary available.,IPI,en,Seeking Alpha
2019-03-11 16:30:51-05:00,Intrepid Potash Q4 2018 Earnings Preview,No summary available.,IPI,en,Seeking Alpha
2019-02-22 11:45:00-05:00,Intrepid Potash: Betting On Blue!,"Update to two previous reports, ‘Betting on Bob!’ and ‘Betting on Joc!’, and an introduction to the next leg of the story with the 'Bet on Blue!' The Bet on Bob",IPI,en,Seeking Alpha
